|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.7 USD | +1.33% |
|
-5.81% | -4.97% |
| May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
| May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
INmune Bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.014 million compared to USD 0.038 million a year ago. Net loss was USD 11.03 million compared to USD 6.54 million a year ago.
Basic loss per share from continuing operations was USD 0.61 compared to USD 0.36 a year ago. Diluted loss per share from continuing operations was USD 0.61 compared to USD 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.97% | 212M | |
| +9.99% | 115B | |
| +12.01% | 106B | |
| -3.07% | 24.69B | |
| -1.11% | 21.97B | |
| -5.15% | 19.27B | |
| -6.90% | 17.56B | |
| -39.36% | 17.32B | |
| +5.82% | 14.03B | |
| +33.05% | 12.13B |
INMUNE BIO, INC. 
